275 related articles for article (PubMed ID: 20500346)
1. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study.
Munir F; Burrows J; Yarker J; Kalawsky K; Bains M
J Clin Nurs; 2010 May; 19(9-10):1362-70. PubMed ID: 20500346
[TBL] [Abstract][Full Text] [Related]
2. Cognitive intervention for breast cancer patients undergoing adjuvant chemotherapy: a needs analysis.
Munir F; Kalawsky K; Lawrence C; Yarker J; Haslam C; Ahmed S
Cancer Nurs; 2011; 34(5):385-92. PubMed ID: 21242770
[TBL] [Abstract][Full Text] [Related]
3. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer.
Kennedy F; Haslam C; Munir F; Pryce J
Eur J Cancer Care (Engl); 2007 Jan; 16(1):17-25. PubMed ID: 17227349
[TBL] [Abstract][Full Text] [Related]
4. Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy?
Player L; Mackenzie L; Willis K; Loh SY
Aust Occup Ther J; 2014 Aug; 61(4):230-40. PubMed ID: 24499127
[TBL] [Abstract][Full Text] [Related]
5. Women's perceptions of the effectiveness of telephone support and education on their adjustment to breast cancer.
Chamberlain Wilmoth M; Tulman L; Coleman EA; Stewart CB; Samarel N
Oncol Nurs Forum; 2006 Jan; 33(1):138-44. PubMed ID: 16470242
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Quesnel C; Savard J; Ivers H
Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
[TBL] [Abstract][Full Text] [Related]
7. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
[TBL] [Abstract][Full Text] [Related]
10. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
[TBL] [Abstract][Full Text] [Related]
11. Facilitated peer support in breast cancer: a pre- and post-program evaluation of women's expectations and experiences of a facilitated peer support program.
Power S; Hegarty J
Cancer Nurs; 2010; 33(2):E9-16. PubMed ID: 20142745
[TBL] [Abstract][Full Text] [Related]
12. Renaming "chemobrain".
Hurria A; Somlo G; Ahles T
Cancer Invest; 2007 Sep; 25(6):373-7. PubMed ID: 17882646
[TBL] [Abstract][Full Text] [Related]
13. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
14. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
15. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
Hurria A; Goldfarb S; Rosen C; Holland J; Zuckerman E; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Robson M; Currie VE; Theodoulou M; Norton L; Hudis C
Breast Cancer Res Treat; 2006 Aug; 98(3):343-8. PubMed ID: 16541322
[TBL] [Abstract][Full Text] [Related]
16. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
Schagen SB; Das E; van Dam FS
Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
[TBL] [Abstract][Full Text] [Related]
17. Cognitive adverse effects of chemotherapy in breast cancer patients.
Correa DD; Ahles TA
Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
[TBL] [Abstract][Full Text] [Related]
18. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
Paraska K; Bender CM
Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
[TBL] [Abstract][Full Text] [Related]
19. Domains of distress: the experience of breast cancer in Australia.
Steginga S; Occhipinti S; Wilson K; Dunn J
Oncol Nurs Forum; 1998 Jul; 25(6):1063-70. PubMed ID: 9679264
[TBL] [Abstract][Full Text] [Related]
20. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
